MicroRNAs as Potential Mediators for Cigarette Smoking Induced Atherosclerosis

Int J Mol Sci. 2018 Apr 6;19(4):1097. doi: 10.3390/ijms19041097.

Abstract

Smoking increases the risk of atherosclerosis-related events, such as myocardial infarction and ischemic stroke. Recent studies have examined the expression levels of altered microRNAs (miRNAs) in various diseases. The profiles of tissue miRNAs can be potentially used in diagnosis or prognosis. However, there are limited studies on miRNAs following exposure to cigarette smoke (CS). The present study was designed to dissect the effects and cellular/molecular mechanisms of CS-induced atherosclerogenesis. Apolipoprotein E knockout (ApoE KO) mice were exposed to CS for five days a week for two months at low (two puffs/min for 40 min/day) or high dose (two puffs/min for 120 min/day). We measured the area of atherosclerotic plaques in the aorta, representing the expression of miRNAs after the exposure period. Two-month exposure to the high dose of CS significantly increased the plaque area in aortic arch, and significantly upregulated the expression of atherosclerotic markers (VCAM-1, ICAM-1, MCP1, p22phox, and gp91phox). Exposure to the high dose of CS also significantly upregulated the miRNA-155 level in the aortic tissues of ApoE KO mice. Moreover, the expression level of miR-126 tended to be downregulated and that of miR-21 tended to be upregulated in ApoE KO mice exposed to the high dose of CS, albeit statistically insignificant. The results suggest that CS induces atherosclerosis through increased vascular inflammation and NADPH oxidase expression and also emphasize the importance of miRNAs in the pathogenesis of CS-induced atherosclerosis. Our findings provide evidence for miRNAs as potential mediators of inflammation and atherosclerosis induced by CS.

Keywords: NADPH oxidase; atherosclerosis; cigarette smoke; microRNAs.

MeSH terms

  • Animals
  • Aorta / metabolism
  • Aorta / pathology
  • Apolipoproteins E / genetics
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism*
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism
  • Cigarette Smoking / adverse effects*
  • Cytochrome b Group / genetics
  • Cytochrome b Group / metabolism
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / metabolism
  • Mice
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • NADPH Oxidase 2 / genetics
  • NADPH Oxidase 2 / metabolism
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • Vascular Cell Adhesion Molecule-1 / genetics
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • Apolipoproteins E
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Cytochrome b Group
  • MicroRNAs
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • Cyba protein, mouse